Indian Pharma Monitoring Coronavirus Fallout On Production
Zhejiang Major Supply Base For Intermediates, APIs
With several Chinese manufacturing facilities shut at least till 10 February, Indian pharma companies are keeping a close watch on the evolving coronavirus situation. API inventory can last for a while, but if intermediates supplies don’t resume soon the fallout could be grim.
